GLOBAL PHARMAPARTNERS, INC. – AN EXCITING INVESTMENT OPPORTUNITY FOR THE USA AND GLOBAL PHARMACEUTICAL INDUSTRY… A FAST-GROWING BUSINESS THAT WILL GROW EVEN FASTER WITH YOUR INVESTMENT.
Global PharmaPartners, Inc was founded in 2006 and headed for $20,000,000 in top line revenues by 2026 (conservative projection based on discount rate of 25% with additional attrition). The sales will grow up to $60 million by 2006 with sufficient investment.
Global PharmaPartners, Inc (GPP) is a fast-growing US and global pharmaceutical business looking to expand even more rapidly by taking on investment. GPP is a US Based company in existence since 2012 partnering with many research and development pharmaceutical companies around the globe to source, develop and file with the FDA, EMA, MHRA, ANVISA, WHO and many other regulatory bodies to launch pharmaceutical products into the USA and globally. GPP has reached a point now (100% privately held company by Mr. Robert L Camerer, CEO and owner) where we will need external investment to develop complex products on our own in order to grow the business according to our current 2021 to 2026 business plan.
For An investment of $1.25 million (5%) to 18 million $USD (70%), as well as commitment to further invest in valuable complex generic and branded drugs, will allow you to obtain a majority stake in GPP, which we forecast to grow exponentially in the next few years. Also, through our extensive relationships with development partners around the globe, we already have access to the complex generic and branded drugs that we seek to invest in, as well as a great GLOBAL team to support our future growth. The projected revenues and really earnings before income tax (as our overhead is in the range of $1 million only per year) is $20 million per year by 2026 (5 years from now) just with the current pharmaceutical products that are either approved or in the pipeline.
ALSO CONSIDER FOR EXAMPLE: $1.25 Million for 5% of the company and $5 Million for 20% OF COMPANY....OR ANYWHERE BETWEEN 5% TO 70% OWNERSHIP BY INVESTOR FOR CORRESPONDING INVESTMENT AMOUNT
If you would like to discuss further the attached presentation in detail at your earliest convenience please let me know your availability.
Thank You
======================
Rob Camerer
Chief Executive Officer
Global PharmaPartners, INC
(A Delaware Corporation)
Missouri Headquarters:
4922 S Eldon Avenue
Springfield, Missouri 65810
Mobile Phone: +1-417-770-4600
Springfield, MO Office Phone: +1-417-885-7000
Ready to Ask For Funding for your company?
Post a Funding Request